These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 21592228)

  • 1. Portal venous invasion: the single most independent risk factor for immediate postoperative recurrence of hepatocellular carcinoma.
    Choi KK; Kim SH; Choi SB; Lim JH; Choi GH; Choi JS; Kim KS
    J Gastroenterol Hepatol; 2011 Nov; 26(11):1646-51. PubMed ID: 21592228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The preoperative positivity for serum hepatitis B e antigen did not affect overall survival after curative resection of hepatitis B virus-related hepatocellular carcinoma.
    Choi GH; Kim DH; Choi SB; Kang CM; Kim KS; Choi JS; Lee WJ; Han KH; Chon CY; Kim BR
    J Gastroenterol Hepatol; 2009 Mar; 24(3):391-8. PubMed ID: 19032452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors correlated with portal venous invasion by hepatocellular carcinoma: univariate and multivariate analyses of 232 resected cases without preoperative treatments.
    Adachi E; Maeda T; Kajiyama K; Kinukawa N; Matsumata T; Sugimachi K; Tsuneyoshi M
    Cancer; 1996 May; 77(10):2022-31. PubMed ID: 8640665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of hepatic venous trunk invasion and prognostic factors in patients with hepatocellular carcinomas that had come into contact with the trunk of major hepatic veins.
    Matsuda M; Suzuki T; Kono H; Fujii H
    J Hepatobiliary Pancreat Surg; 2007; 14(3):289-96. PubMed ID: 17520205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The value of portal vein chemotherapy after radical resection in delaying intrahepatic recurrence of stage II primary hepatocellular carcinoma].
    Zhang GQ; Ge L; Ding W; Li HJ
    Ai Zheng; 2008 Dec; 27(12):1297-301. PubMed ID: 19079997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors of the recurrence of hepatocellular carcinoma originating from residual cancer cells after hepatectomy.
    Shimada M; Hasegawa H; Gion T; Shirabe K; Taguchi K; Takenaka K; Tanaka S; Sugimachi K
    Hepatogastroenterology; 1999; 46(28):2469-75. PubMed ID: 10522022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of microscopic portal vein invasion by hepatocellular carcinoma: measurement of portal perfusion defect area ratio.
    Shirabe K; Kajiyama K; Abe T; Sakamoto S; Fukuya T; Akazawa K; Morita K; Maehara Y
    J Gastroenterol Hepatol; 2009 Aug; 24(8):1431-6. PubMed ID: 19486447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma.
    Poon RT; Fan ST; Ng IO; Lo CM; Liu CL; Wong J
    Cancer; 2000 Aug; 89(3):500-7. PubMed ID: 10931448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors affecting the prognosis of patients with hepatocellular carcinoma invading the portal vein--a retrospective analysis using 952 consecutive HCC patients.
    Koike Y; Nakagawa K; Shiratori Y; Shiina S; Imamura M; Sato S; Obi S; Teratani T; Hamamura K; Yoshida H; Omata M
    Hepatogastroenterology; 2003; 50(54):2035-9. PubMed ID: 14696460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microvascular invasion in patients with hepatocellular carcinoma and its predictable clinicopathological factors.
    Sumie S; Kuromatsu R; Okuda K; Ando E; Takata A; Fukushima N; Watanabe Y; Kojiro M; Sata M
    Ann Surg Oncol; 2008 May; 15(5):1375-82. PubMed ID: 18324443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of perioperative blood transfusion on intrahepatic recurrence after curative resection of hepatocellular carcinoma.
    Makino Y; Yamanoi A; Kimoto T; El-Assal ON; Kohno H; Nagasue N
    Am J Gastroenterol; 2000 May; 95(5):1294-300. PubMed ID: 10811342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Risk factors for early recurrence after surgical resection for hepatocellular carcinoma].
    Park UJ; Kim YH; Kang KJ; Lim TJ
    Korean J Hepatol; 2008 Sep; 14(3):371-80. PubMed ID: 18815460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary versus salvage living donor liver transplantation for patients with hepatocellular carcinoma: impact of microvascular invasion on survival.
    Moon JI; Kwon CH; Joh JW; Choi GS; Jung GO; Kim JM; Shin M; Choi SJ; Kim SJ; Lee SK
    Transplant Proc; 2012 Mar; 44(2):487-93. PubMed ID: 22410053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrence after liver resection for hepatocellular carcinoma: risk factors, treatment, and outcomes.
    Shah SA; Cleary SP; Wei AC; Yang I; Taylor BR; Hemming AW; Langer B; Grant DR; Greig PD; Gallinger S
    Surgery; 2007 Mar; 141(3):330-9. PubMed ID: 17349844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemoembolization for hepatocellular carcinoma: multivariate analysis of predicting factors for tumor response and survival in a 362-patient cohort.
    Hu HT; Kim JH; Lee LS; Kim KA; Ko GY; Yoon HK; Sung KB; Gwon DI; Shin JH; Song HY
    J Vasc Interv Radiol; 2011 Jul; 22(7):917-23. PubMed ID: 21571545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Akt phosphorylation is a risk factor for early disease recurrence and poor prognosis in hepatocellular carcinoma.
    Nakanishi K; Sakamoto M; Yamasaki S; Todo S; Hirohashi S
    Cancer; 2005 Jan; 103(2):307-12. PubMed ID: 15593087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Operative blood loss independently predicts recurrence and survival after resection of hepatocellular carcinoma.
    Katz SC; Shia J; Liau KH; Gonen M; Ruo L; Jarnagin WR; Fong Y; D'Angelica MI; Blumgart LH; Dematteo RP
    Ann Surg; 2009 Apr; 249(4):617-23. PubMed ID: 19300227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic benefit of selective portal vein occlusion during hepatic resection for hepatocellular carcinoma.
    Makino I; Chijiiwa K; Kondo K; Ohuchida J; Kai M
    Surgery; 2005 Jun; 137(6):626-31. PubMed ID: 15933630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological risk factors linked to recurrence pattern after curative hepatic resection for hepatocellular carcinoma--results of 152 resected cases.
    Shirabe K; Wakiyama S; Gion T; Motomura K; Koyanagi T; Sakamoto S; Nagaie T
    Hepatogastroenterology; 2007; 54(79):2084-7. PubMed ID: 18251164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors influencing survival in hepatocellular carcinoma patients with macroscopic portal vein tumor thrombosis after surgery, with special reference to time dependency: a single-center experience of 381 cases.
    Zhou J; Tang ZY; Wu ZQ; Zhou XD; Ma ZC; Tan CJ; Shi YH; Yu Y; Qiu SJ; Fan J
    Hepatogastroenterology; 2006; 53(68):275-80. PubMed ID: 16608039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.